User profiles for Rüdiger Groß
 | Rüdiger M GroßUlm University Hospital Verified email at uni-ulm.de Cited by 3886 |
[PDF][PDF] SARS-CoV-2 variants B. 1.351 and P. 1 escape from neutralizing antibodies
The global spread of SARS-CoV-2/COVID-19 is devastating health systems and economies
worldwide. Recombinant or vaccine-induced neutralizing antibodies are used to combat the …
worldwide. Recombinant or vaccine-induced neutralizing antibodies are used to combat the …
SARS-CoV-2 infects and replicates in cells of the human endocrine and exocrine pancreas
Infection-related diabetes can arise as a result of virus-associated β-cell destruction.
Clinical data suggest that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), …
Clinical data suggest that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), …
Detection of SARS-CoV-2 in human breastmilk
It remains unclear whether severe acute respiratory syndrome corona virus 2 (SARSCoV2)
can be shed into breastmilk and transmitted to a child through breastfeeding. Recent …
can be shed into breastmilk and transmitted to a child through breastfeeding. Recent …
IFITM proteins promote SARS-CoV-2 infection and are targets for virus inhibition in vitro
Interferon-induced transmembrane proteins (IFITMs 1, 2 and 3) can restrict viral pathogens,
but pro- and anti-viral activities have been reported for coronaviruses. Here, we show that …
but pro- and anti-viral activities have been reported for coronaviruses. Here, we show that …
Virucidal efficacy of different oral rinses against severe acute respiratory syndrome coronavirus 2
The ongoing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic
creates a significant threat to global health. Recent studies suggested the significance of throat …
creates a significant threat to global health. Recent studies suggested the significance of throat …
Heterologous ChAdOx1 nCoV-19 and BNT162b2 prime-boost vaccination elicits potent neutralizing antibody responses and T cell reactivity against prevalent SARS …
R Groß, M Zanoni, A Seidel, C Conzelmann, A Gilg… - …, 2022 - thelancet.com
Background Heterologous COVID-19 vaccination regimens combining vector- and mRNA-based
vaccines are already administered, but data on solicited adverse reactions, …
vaccines are already administered, but data on solicited adverse reactions, …
Robust and durable serological response following pediatric SARS-CoV-2 infection
The quality and persistence of children’s humoral immune response following SARS-CoV-2
infection remains largely unknown but will be crucial to guide pediatric SARS-CoV-2 …
infection remains largely unknown but will be crucial to guide pediatric SARS-CoV-2 …
SARS-CoV-2 is restricted by zinc finger antiviral protein despite preadaptation to the low-CpG environment in humans
Recent evidence shows that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
is sensitive to interferons (IFNs). However, the most effective types of IFNs and the …
is sensitive to interferons (IFNs). However, the most effective types of IFNs and the …
Alpha-1 antitrypsin inhibits TMPRSS2 protease activity and SARS-CoV-2 infection
SARS-CoV-2 is a respiratory pathogen and primarily infects the airway epithelium. As our
knowledge about innate immune factors of the respiratory tract against SARS-CoV-2 is limited, …
knowledge about innate immune factors of the respiratory tract against SARS-CoV-2 is limited, …
[PDF][PDF] Guanylate-binding proteins 2 and 5 exert broad antiviral activity by inhibiting furin-mediated processing of viral envelope proteins
Guanylate-binding protein (GBP) 5 is an interferon (IFN)-inducible cellular factor reducing
HIV-1 infectivity by an incompletely understood mechanism. Here, we show that this activity is …
HIV-1 infectivity by an incompletely understood mechanism. Here, we show that this activity is …
